v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 640,075 $ 1,695,994
Accounts receivable, net of allowance for credit losses of $58,858 and $60,551 at March 31, 2026, and December 31, 2025, respectively 1,321,532 1,201,061
Prepaid cost of revenue 82,735 70,216
Prepaid expenses and other current assets 150,601 204,997
Contract assets 130,889 91,956
Total Current Assets 2,325,832 3,264,224
Property and equipment, net 406,858 450,104
Operating lease right-of-use assets, net 328,638 370,345
Intangible assets, net 694,205 881,075
Goodwill 19,900,550 19,900,550
Prepaid cost of revenue, net of current portion 29,989
Other assets 131,966 131,966
Total Assets 23,788,049 25,028,253
Current Liabilities:    
Accounts payable 3,174,965 2,682,762
Accrued expenses and other current liabilities 1,499,838 1,592,874
Deferred revenue 895,433 1,024,725
Lease liabilities 186,435 181,478
Loans payable 83,075 83,983
Line of credit 2,009,988 2,172,667
Total Current Liabilities 7,849,734 7,738,489
Deferred revenue, net of current portion 22,261 33,673
Loans payable, net of current portion 3,605
Lease liabilities, net of current portion 213,272 260,572
Total Liabilities 8,085,267 8,036,339
Commitments and Contingencies (Note 10)  
Stockholders’ Equity:    
Common Stock, $.00001 par value; 1,300,000,000 shares authorized; 45,815,474 and 45,173,774 shares issued at March 31, 2026 and December 31, 2025, respectively; 45,313,337 and 44,671,637 outstanding at March 31, 2026 and December 31, 2025, respectively 458 451
Additional paid-in capital 206,060,872 205,462,426
Treasury stock, at cost (502,137 shares) (290,737) (290,737)
Accumulated other comprehensive income (loss) (4,288) (10,689)
Accumulated deficit (191,930,423) (190,341,517)
Total Stockholders’ Equity 13,835,882 14,819,934
Total Liabilities, Temporary Equity and Stockholders’ Equity 23,788,049 25,028,253
Series B Preferred Stock [Member]    
Current Liabilities:    
Temporary Equity: Series B Preferred Stock; 2,396 shares issued at March 31, 2026 and December 31, 2025, respectively; 1,778 and 2,081 shares outstanding at March 31, 2026 and December 31, 2025, respectively 1,866,900 2,171,980
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred Stock, $.00001 par value; 50,000,000 shares authorized: Series A Preferred Stock; 0 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively